Henry Schein (NSDQ:HSIC) said yesterday that it’s planning more changes for its business after announcing the spinout of its animal health business and a joint venture for its dental software operation earlier this year. In a terse regulatory filing yesterday, Melville, N.Y.-based Schein said it’s “committed to an initiative to rationalize its operations and provide […]
Henry Schein, Internet Brands form dental-software focused JV Henry Schein One
Henry Schein (NSDQ:HSIC) said yesterday that it and Internet Brands formed joint venture Henry Schein One, which aims to produce integrated dental technology focused on improving practice management, marketing and patient communication. The deal was originally announced on April 3, Melville, N.Y.-based Henry Schein said, and financial terms of the agreement have not been disclosed. “With […]
Henry Schein shares down despite Street-beating Q1
Shares in Henry Schein (NSDQ:HSIC) have fallen today despite the medical device maker beating expectations on Wall Street with its first quarter 2018 earnings release. The Melville, N.Y.-based company posted profits of $140.2 million, or 91¢ per share, on sales of $3.2 billion for the three months ended March 31, seeing the bottom-line shrink 0.4% while […]
Hospitals sue BD, distributors, GPOs over alleged safety syringe monopoly
A group of healthcare providers levied a purported class action against BD, its distributors and group purchasing organizations accusing them of running a monopoly on the U.S. safety syringe market. The lawsuit, brought in the U.S. District Court for Southern Illinois, was filed on behalf of “healthcare providers nationwide” by a group of providers “who […]
Medtronic taps former JP Morgan analyst Weinstein for strategy SVP | Personnel Moves – May 7, 2018
Medtronic (NYSE:MDT) said today it tapped former J.P. Morgan Chase & Co. analyst Mike Weinstein as its strategy senior VP. Prior to joining Medtronic, Weinstein served as a managing director for JP Morgan’s equity research healthcare team, holding positions within the unit for more than 20 years, the Fridley, Minn.-based company said. “We are excited to […]
Schein to spin out animal health biz in merger with Vets First Choice
Henry Schein (NSDQ:HSIC) said today it plans to spin off its Animal Health business and merge it with Vets First Choice to create a new combined animal health business which will operate under the moniker Vets First Corp. The new company aims to use advanced data analytics, practice management software and other specialized technology to support […]
Biolase CEO Flynn steps down | Personnel Moves – April 13, 2018
Biolase (NSDQ:BIOL) said this week its CEO Harold Flynn has resigned from the company to pursue other interests, and that current CFO John Beaver will step in to act as interim CEO. The transition will be made immediately, the Irvine, Calif.-based company said. “I would like to thank Harold for the leadership and commitment he has […]
FTC files complaint against Schein, Benco, Patterson over alleged denial of biz to buying groups
The U.S. Federal Trade Commission this week filed a complaint against Henry Schein (NSDQ:HSIC), Patterson (NSDQ:PDCO) and Benco alleging violations of US antitrust law by conspiring to refuse to provide discounts to or to serve buying groups representing dental practitioners, according to a new FTC posting. The three companies, which the FTC claims control more than 85% of […]
Henry Schein shares fall on Q3 EPS miss
Shares in Henry Schein (NSDQ:HSIC) have fallen today after the company posted third quarter earnings which beat sales but missed earning per share expectations on Wall Street. The Melville, N.Y.-based company posted profits of $138 million, or 87¢ per share, on sales of $3.2 billion for the 3 months ended September 30, seeing the bottom-line grow […]
Henry Schein inks distro deal with Cerebral Assessment Systems
Henry Schein (NSDQ:HSIC) said today it inked a deal with Cerebral Assessment Systems to distribute its Cognivue cognitive assessment screening device designed to detect early signs of dementia. Melville, N.Y.-based Henry Schein touted the Cognivue as the 1st such device approved by the FDA. The device is designed to allow practitioners to monitor current brain health and […]
Henry Schein board approves 2-for-1 split
Henry Schein (NSDQ:HSIC) said today its board of directors approved a 2-for-1 split of the company’s common stock. Through the deal, each Henry Schein shareholder as of September 1 will receive a dividend of 1 additional share for every share held, with trading beginning on a split-adjusted basis on September 15. Henry Schein touted the split […]
- 1
- 2
- 3
- 4
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
Google+